Loading...
Genital human papillomavirus infection is the most common sexually transmitted viral infection in the United States. This randomized double-blind trial evaluated whether topical podofilox, a cytotoxic drug, was effective in decreasing numbers of genital warts in women.
Seventy-two women aged 18 years or older with biopsy- proven "condyloma acuminata" or "koilocytotic atypia" were studied. Podofilox and placebo were self-administered (as a topical cream or buffered solution) to external warts for 3 consecutive days per week over a 2- to 4-week period. The average wart count was 9.5 at baseline. At 4 weeks, women receiving podofilox had 74 percent fewer lesions, as compared with 18 percent fewer in women receiving placebo.
At 10 weeks, a relaps…